Fig 1.
Participant flow diagram for REBOOT study, San Francisco 2014–2016.
Table 1.
Baseline characteristics of REBOOT participants, by treatment arm, San Francisco 2014–2016.
Fig 2.
(a) Proportion of REBOOT and control participants with any overdose in preceding 4 months, San Francisco 2014–2016; (b) Mean number of overdoses in preceding 4 months per REBOOT and control participant, San Francisco 2014–2016.
Table 2.
Opioid overdose outcomes and sensitivity analyses among REBOOT compared to control participants, San Francisco 2014–2016.